Journal article
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: First report from the prospective Lynch syndrome database
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, A Lindblom, F Macrae, I Blanco, R Sijmons, J Jeffries, H Vasen, J Burn, S Nakken, E Hovig, EA Rødland, K Tharmaratnam, WH De Vos Tot Nederveen Cappel, J Hill, J Wijnen Show all
Gut | BMJ PUBLISHING GROUP | Published : 2017
Abstract
Objective Estimates of cancer risk and the effects of surveillance in Lynch syndrome have been subject to bias, partly through reliance on retrospective studies. We sought to establish more robust estimates in patients undergoing prospective cancer surveillance. Design We undertook a multicentre study of patients carrying Lynch syndrome-associated mutations affecting MLH1, MSH2, MSH6 or PMS2. Standardised information on surveillance, cancers and outcomes were collated in an Oracle relational database and analysed by age, sex and mutated gene. Results 1942 mutation carriers without previous cancer had follow-up including colonoscopic surveillance for 13 782 observation years. 314 patients dev..
View full abstractGrants
Awarded by Medical Research Council
Funding Acknowledgements
The Finnish contribution was supported by The Finnish Cancer Foundation, The Sigrid Juselius Foundation, Mary and Georg Ehrnrooth foundation and State Research Funding. The Spanish contribution has been funded by the Spanish Ministry of Economy and Competitiveness SAF2012-33636 (GC); the Carlos III Health Institute; RTICC (RD12/0036/0008); the Scientific Foundation Asociacion Espanola Contra el Cancer; and the Government of Catalonia (2014 SGR 338) and the Welsh Contribution by the Wales Gene Park.